UPDATE: Mattel (MAT) Tops Q1 EPS by 1c, Sales Beat
Get Alerts MAT Hot Sheet
Revenue Growth %: +7.8%
Financial Fact:
Interest (income): -2.48M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Mattel (NASDAQ: MAT) reported Q1 EPS of ($0.08), 1 cent better than the analyst estimate of ($0.09). Revenue for the quarter came in at $922.7 million versus the consensus estimate of $896.44 million.
Sales by Brand
Mattel Girls and Boys Brands
For the first quarter, worldwide gross sales for Mattel Girls & Boys Brands were $605.2 million, up 1% in constant currency versus the prior year. Worldwide gross sales for the Barbie brand were down 5% in constant currency. In the quarter, retail sales for Barbie were up on a global basis driven by a strong performance in the United States, partially offset by a decline in international markets. Worldwide gross sales for Other Girls brands were down 1% in constant currency. Worldwide gross sales for the Wheels category, which includes the Hot Wheels and Matchbox® brands, were up 10% in constant currency. Worldwide gross sales for the Entertainment business, which includes Radica® and Games, were up 4% in constant currency.
Fisher-Price Brands
First quarter worldwide gross sales for Fisher-Price Brands, which includes the Fisher-Price Core, Fisher-Price Friends and Power Wheels® brands, were $264.0 million, up 3% in constant currency versus the prior year.
American Girl Brands
First quarter gross sales for American Girl Brands, which offers American Girl-branded products directly to consumers, were $106.1 million, flat versus the prior year in constant currency.
Construction and Arts & Crafts Brands
First quarter gross sales for Construction and Arts & Crafts Brands, which includes the MEGA BLOKS® and RoseArt® brands, were $38.3 million. Mattel acquired MEGA Brands Inc. on April 30, 2014.
For earnings history and earnings-related data on Mattel (MAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- Hermès can regain momentum despite China weakness, Jefferies says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share